Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 10:48 PM
Study NCT ID:
NCT04931667
Status:
TERMINATED
Last Update Posted:
2022-01-10
First Post:
2021-06-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee
Sponsor:
Biosplice Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-04
First Submit QC Date:
None
Study First Post Date:
2021-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-17
Last Update Post Date:
2022-01-10
Last Update Post Date Type:
ACTUAL